The AAPP board officer transition will occur on July 1. AAPP thanks outgoing board members Robert Haight, PharmD, BCPP, and Sarah Melton Thomason, PharmD, BCPP, BCACP, FASCP, for their dedicated service.
Incoming President-Elect Dr. Michelle Geier, PharmD, BCPP
Dr. Michelle Geier graduated from University of Washington School of Pharmacy and completed a pharmacy practice PGY1 residency at the VA Puget Sound and a psychiatric pharmacy PGY2 residency at University of California San Francisco/San Francisco Department of Public Health. She began working with the San Francisco Department of Public Health Behavioral Health Service (SFDPH BHS) as a psychiatric and substance use disorders clinical pharmacist in 2012. In her current practice, she provides ambulatory care psychiatric services in a public health specialty mental health clinic. Some of the projects she has worked on include naloxone prescribing by pharmacists, deprescribing sedative-hypnotics and initiating buprenorphine in high risk areas with transitions to outpatient (including jail, inpatient and the emergency department).
|
|
Incoming Member-at-Large Dr. Jolene Bostwick, PharmD, BCPS, BCPP Dr. Bostwick graduated in 2004 from the University of Michigan College of Pharmacy and completed a specialty residency in psychiatric pharmacy with Kaiser Permanente in Denver, CO. She subsequently practiced as a “front line” psychiatric pharmacist for 15 years, developing pharmacy services in inpatient and outpatient psychiatry before transitioning into her current administrative role as Assistant Dean in February 2020. |
|
Incoming Member-at-Large Dr. Kristina Reinstatler, PharmD, MBA, BCPP Dr. Reinstatler graduated from the University of Cincinnati and completed a residency at the Chillicothe VA and worked part time until she was hired as a Clinical Staff Pharmacist at University of Cincinnati Medical Center. She earned her BCPP 2012 and transitioned to a Clinical Pharmacy Specialist, which grew to encompass psychiatry and addiction sciences. Dr. Reinstatler recently transitioned to a Drug Policy position at UC. |